Results
1
-
10
of
98
<
1
2
3
...
9
10
>
Pawar PK; Majumdar DK.
Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.
,
AAPS PharmSciTech
[PubMed: 16584143]
[DOI: 10.1208/pt070113]
Suzuki T; Kataoka H; Ida T; Kamachi K; Mikuniya T.
Bactericidal activity of topical antiseptics and their gargles against Bordetella pertussis.
,
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
[PubMed: 21968967]
[DOI: 10.1007/s10156-011-0312-4]
Lopes JF; Hubatsch DA; Amaris P.
Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
,
BMC ophthalmology
[DOI: 10.1186/s12886-015-0151-7]
Leitritz MA; Lipp HP; Voykov B; Ziemssen F.
[Original preparations versus generics--latanoprost: how similar is different?].
,
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
[DOI: 10.1007/s00347-014-3097-x]
Konstas AG; Voudouragkaki IC; Boboridis KG; Haidich AB; Paschalinou E; Giannopoulos T; Dragoumis ND; Makridis AK; Kahook MY.
24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost.
,
Advances in therapy
[DOI: 10.1007/s12325-014-0125-9]
Crichton AC; Vold S; Williams JM; Hollander DA.
Ocular surface tolerability of prostaglandin analogs and prostamides in patients with glaucoma or ocular hypertension.
,
Advances in therapy
[DOI: 10.1007/s12325-013-0014-7]
Liang H; Brignole-Baudouin F; Pauly A; Riancho L; Baudouin C.
Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study.
,
Advances in therapy
[DOI: 10.1007/s12325-011-0003-7]
Ryan G Jr; Fain JM; Lovelace C; Gelotte KM.
Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system.
,
BMC ophthalmology
[DOI: 10.1186/1471-2415-11-8]
Ammar DA; Noecker RJ; Kahook MY.
Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
,
Advances in therapy
[DOI: 10.1007/s12325-010-0070-1]
Khoh-Reiter S; Jessen BA.
Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model.
,
BMC ophthalmology
[DOI: 10.1186/1471-2415-9-5]
<
1
2
3
...
9
10
>